Catalyst Wire Dossier Catalyst Wire Dossier

AFFITOPE AD01

· Affiris AG
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AFFITOPE AD01, covering 2010-05-27 to 2010-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease [Phase 1]

See pricing